Main distributor to Brazil and Latin America for analytical reference substances  |  Welcome! Olá! Hola! Español  |  +1.919.484.7555
You are here: Home /Business /Baxalta to collaborate with Symphogen in $1.6bn immuno-oncology deal – Pharmaceutical Technology

Baxalta to collaborate with Symphogen in $1.6bn immuno-oncology deal – Pharmaceutical Technology

by JMC on January 5, 2016

US-based biopharmaceutical firm Baxalta has agreed to pay Danish biotech firm Symphogen up to $1.6bn for the rights to co-develop six experimental cancer drugs.

Source: Baxalta to collaborate with Symphogen in $1.6bn immuno-oncology deal – Pharmaceutical Technology

Previous post:

Next post: